GLP-1 Receptor Agonists and Nutrition
A special issue of Nutrients (ISSN 2072-6643). This special issue belongs to the section "Nutrition and Diabetes".
Deadline for manuscript submissions: 25 March 2026 | Viewed by 12
Special Issue Editor
Interests: cardiovascular system; cardiac sarcoidosis; coronary artery disease; vein anastomosis; dilated cardiomyopathy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Glucagon-like peptide-1 (GLP-1) receptor agonists are analogs of GLP-1, one of the incretin hormones secreted by the gastrointestinal tract. They were initially developed as a treatment for type 2 diabetes. Subsequently, the weight loss effects of these agents gained attention, and they have been approved for use in weight reduction when health complications associated with obesity are present.
However, it has been pointed out that because weight loss can be achieved through the use of GLP-1 receptor agonists alone, the fundamental components of weight management—dietary and exercise therapy—are often neglected. Additionally, appropriate nutritional therapy, including consuming sufficient energy without skipping meals or excessively restricting carbohydrates, is considered beneficial in preventing hypoglycemia in patients using incretin-based medications.
In this Special Issue, we aim to invite papers from various perspectives on the topic of “GLP-1 Receptor Agonists and Nutrition”.
Dr. Kazufumi Nakamura
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nutrients is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- obesity
- diabetes
- dietary therapy
- exercise therapy
- muscle mass
- body fat
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
